STAAR SURGICAL CO·4

Jun 22, 4:05 PM ET

Zhou Lilian Yansheng 4

4 · STAAR SURGICAL CO · Filed Jun 22, 2026

Research Summary

AI-generated summary of this filing

Updated

STAA Director Zhou Lilian Yansheng Receives Equity Award

What Happened

  • Director Zhou Lilian Yansheng received grants on June 18, 2026 consisting of 3,091 restricted stock units and 5,572 stock option awards (total = 8,663). The Form 4 reports these as derivative awards at $0.00 per share (typical for RSU/option grants; not a cash purchase or sale).

Key Details

  • Transaction date: June 18, 2026; Form 4 filed: June 22, 2026 (filed four days after the grant).
  • Reported amounts/prices: 3,091 RSUs @ $0.00 and 5,572 options @ $0.00 (total 8,663 awards).
  • Shares owned after transaction: not disclosed in the filing.
  • Footnote: F1 states these are restricted stock units and options granted under the issuer’s annual non-employee director equity program for the 2026–2027 term; they vest in full on the earlier of June 18, 2027 or the issuer’s 2027 Annual Meeting of Shareholders.
  • Timeliness: Filing occurred four days after the grant date, which is later than the typical two-business-day Form 4 deadline.

Context

  • These awards are compensation for director service, not an open-market purchase or sale. RSUs convert to shares upon vesting; options give the right to buy shares later (exercise required to obtain shares).
  • Because this is an equity award, it does not signal an immediate sale or purchase by the director and should be viewed as standard director compensation unless further trading follows.

Insider Transaction Report

Form 4
Period: 2026-06-18
Transactions
  • Award

    Restricted Stock Units

    [F1]
    2026-06-18+3,0913,091 total
    Exercise: $0.00Common Stock (3,091 underlying)
  • Award

    Common Stock Options

    [F1]
    2026-06-18+5,5725,572 total
    Exercise: $29.12From: 2027-06-18Exp: 2036-06-17Common Stock (5,572 underlying)
Footnotes (1)
  • [F1]Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.
Signature
/s/ Kathleen Determann as attorney-in-fact for Lilian Y. Zhou|2026-06-22

Documents

1 file
  • 4
    ownership.xmlPrimary

    4